Kevzara subcutaneous injection 200mg syringe, manufactured by Sanofi, contains Sarilumab (genetical recombination) (YJ code: 3999444G2029, 200mg 1.14mL 1 tube). This IL-6 receptor antagonist is used for moderately to severely active rheumatoid arthritis in adults who have had an inadequate response or intolerance to other DMARDs.
Kevzara subcutaneous injection 200mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).